WATERTOWN, Mass., Feb. 28, 2019 (GLOBE NEWSWIRE) -- SQZ Biotechnologies (SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today announced presentations at the American Association for Cancer Research (AACR) 2019 Annual Meeting being held March 29-April 3, 2019 in Atlanta, Georgia. Poster presentations will detail the benefits of cell squeezing versus electroporation as a technique for engineering cells as well as the clinical potential of the proprietary Cell Squeeze® platform in engineering the next generation of cancer cell therapies.
Details on the presentations are as follows:
Presentation Title: Tumor-specific T cell engineering for enhanced effector function via microfluidic delivery of bioactive molecules
Abstract Number: 1445
Presenter: Luke Cassereau, Ph.D.
Poster Session Date and Time: Monday Apr. 1, 2019 8:00 a.m. – 12:00 p.m. EST
Location: Georgia World Congress Center, Exhibit Hall B, Poster Section 21
Presentation Title: Engineering a new generation of cell therapies for solid tumor oncology using the SQZ platform
Abstract Number: 3187
Presenter: Kelan Hlavaty, Ph.D.
Poster Session Date and Time: Tuesday Apr. 2, 2019 8:00 a.m. – 12:00 p.m. EST
Location: Georgia World Congress Center, Exhibit Hall B, Poster Section 22
Additional details can be found on the conference website.
About SQZ Biotech
SQZ Biotech is a privately held company creating innovative treatments by transforming cells into sophisticated therapeutics. Using its proprietary platform, SQZ has the unique ability to precision engineer any cell type and deliver multiple materials, resulting in powerful, multifunctional cell therapies for a range of diseases with an initial focus on cancer and autoimmune disease. The first applications for the company leverage SQZ’s ability to generate target-specific immune responses, both in activation for the treatment of solid tumors, and immune suppression for the treatment of auto-immune diseases. For more information please visit www.sqzbiotech.com.
SQZ Contact:
Rebecca Cohen
Senior Manager, Corporate Relations
rebecca.cohen@sqzbiotech.com
617-758-8672 ext. 728
Media Contact
Cait Williamson, PhD
LifeSci Public Relations
cait@lifescipublicrelations.com
646-751-4366